Menopausal metabolic syndrome after hysterectomy
Aim. To study indapamide retard 1,5 mg effects in women with menopausal metabolic syndrome (MMS) after hysterectomy. Material and methods. The study involved 25 women (mean age 43.82±4.08 years), who underwent subtotal hysterectomy, with one or two ovaries intact, and suffered from Stage I-II arteri...
Saved in:
Main Authors: | V. I. Podzolkov, L. G. Mozharova, Yu. V. Khomitskaya |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2005-12-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1025 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hypertension and menopause
by: O. D. Ostroumova, et al.
Published: (2019-09-01) -
Diuretics in patients with metabolic disturbances
by: I. E. Chazova, et al.
Published: (2007-04-01) -
Open, multi-center randomized research and clinical program MINOTAUROS: intermediate data analysis
by: I. E. Chazova, et al.
Published: (2006-04-01) -
Metabolic (cytoprotective) therapy of menopausal disturbances
by: S. N. Tolstov, et al.
Published: (2011-06-01) -
Moxonidine for arterial hypertension treatment in menopausal women with metabolic syndrome
by: V. V. Trusov, et al.
Published: (2007-08-01)